Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225322 · ClinicalTrials.gov registry record · Phase 1
Low Intensity Focused Ultrasound in ASD
A Phase 1 study, sponsored by Medical University of South Carolina.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07225322 is a Phase 1 study that has not yet begun recruiting, run by Medical University of South Carolina. The registered enrollment target is 20 participants.
The verdict
NCT07225322, a Phase 1 study, has not yet begun recruiting, sponsored by Medical University of South Carolina.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.
Interventions
- DEVICE Active LIFU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07225322
The ClinicalTrials.gov registry entry for NCT07225322 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Active LIFU is the first listed.
NCT07225322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07225322 about?
NCT07225322 is a clinical study titled "Low Intensity Focused Ultrasound in ASD". This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU st...
What is the current status of trial NCT07225322?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07225322?
The interventions under investigation include: Active LIFU (DEVICE).
Who is sponsoring clinical trial NCT07225322?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.